{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T17:58:57Z","timestamp":1775584737934,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TEIJIN PHARMA LIMITED"},{"DOI":"10.13039\/501100012700","name":"Japan Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Meiji Yasuda Mental Health Foundation"},{"name":"Mitsui Life Social Welfare Foundation"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Science Center Foundation"},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daiichi Sankyo Scholarship Donation Program"},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ontario Graduate Scholarship"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR Vanier Canada Graduate Scholarship"},{"name":"Healthy Brains for Healthy Lives Postdoctoral Fellowship"},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"National Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012120","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007774","name":"Instituto de Ciencia y Tecnolog\u00eda del Distrito Federal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007706","name":"Ministry of Economic Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007706","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation of Ontario"},{"DOI":"10.13039\/100012774","name":"Ontario Academic Health Science Center Alternate Funding Plan Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000243","name":"W. Garfield Weston Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon-Sumitomo Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mochida Pharmaceutical"},{"name":"Meiji-Seika Pharmaceutical"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon-Sumitomo Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/501100002424","name":"Fuji Film RI Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002424","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen Pharmaceutical"},{"name":"Mochida Pharmaceutical"},{"name":"MSD"},{"name":"Nippon Chemipher"},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ono Yakuhin"},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda Yakuhin"},{"DOI":"10.13039\/501100013420","name":"Tsumura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yoshitomi Yakuhin"},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Daiichi Sankyo Scholarship Donation Program"},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji-Seika Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yoshitomi Yakuhin"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pnpbp.2020.109871","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T11:20:36Z","timestamp":1579346436000},"page":"109871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study"],"prefix":"10.1016","volume":"100","author":[{"given":"Ryo","family":"Ochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Tsuchimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tarumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Tsugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Plitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamiyu","family":"Ogyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mallar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pnpbp.2020.109871_bb0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/brain.2011.0071","article-title":"Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains","volume":"1","author":"Alexander","year":"2011","journal-title":"Brain Connect."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","article-title":"An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging","volume":"125","author":"Andersson","year":"2016","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuroimage.2018.09.073","article-title":"Automated quality control for within and between studies diffusion MRI data using a non-parametric framework for movement and distortion correction","volume":"184","author":"Bastiani","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.pnpbp.2020.109871_bb0025","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2018.18040429","article-title":"Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia","author":"Brady","year":"2019","journal-title":"American Journal of Psychiatry."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109871_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2014.05.020","article-title":"A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease","volume":"161","author":"Canu","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2018.08.036","article-title":"White matter integrity associated with severity reductions in positive symptoms after amisulpride treatment in drug-free patients with schizophrenia","volume":"685","author":"Cho","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0045","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fphar.2018.01172","article-title":"Confused connections? Targeting white matter to address treatment resistant schizophrenia","volume":"9","author":"Crocker","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109871_bb0050","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","volume":"47","author":"Demjaha","year":"2017","journal-title":"Psychological medicine"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109871_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1353\/hpu.2017.0070","article-title":"Clinical correlates of treatment response among patients with schizophrenia in a tertiary Nigerian hospital","volume":"28","author":"Ezeme","year":"2017","journal-title":"J. Health Care Poor Underserved"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cne.901800310","article-title":"Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum","volume":"180","author":"Fallon","year":"1978","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109871_bb0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0070","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109871_bb0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/npp.2013.294","article-title":"Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia","volume":"39","author":"Holleran","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"9929","key":"10.1016\/j.pnpbp.2020.109871_bb0080","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: an integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2016","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109871_bb0090","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hbm.23982","article-title":"Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia","volume":"39","author":"Huang","year":"2018","journal-title":"Human brain mapping"},{"key":"10.1016\/j.pnpbp.2020.109871_bb0095","first-page":"1443","article-title":"Dose equivalence of psychotropic drugs: 2006 version","volume":"9","author":"Inagaki","year":"2006","journal-title":"Rinsyo Seishin Yakuri (Jpn. J. Clin. Psychopharmacol.)"},{"issue":"7","key":"10.1016\/j.pnpbp.2020.109871_bb0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","article-title":"Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: A cross-sectional 3T proton magnetic resonance spectroscopy study","volume":"85","author":"Iwata","year":"2019","journal-title":"Biological psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109871_bb0105","article-title":"Determinants of treatment response in first-episode psychosis: an 18 F-DOPA PET study","volume":"1","author":"Jauhar","year":"2018","journal-title":"Molecular psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109871_bb0110","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.11076tx2c","article-title":"Addressing nonresponse in schizophrenia","volume":"73","author":"Kane","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.109871_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109871_bb0120","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mp.2017.170","article-title":"Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group","volume":"23","author":"Kelly","year":"2018","journal-title":"Molecular psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0269881115625114","article-title":"White-matter connectivity related to paliperidone treatment response in patients with schizophrenia","volume":"30","author":"Kim","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109871_bb0130","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2019.18101212","article-title":"White Matter in Schizophrenia Treatment Resistance","author":"Kochunov","year":"2019","journal-title":"Am. J. Psychiatr."},{"issue":"15","key":"10.1016\/j.pnpbp.2020.109871_bb0135","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1017\/S0033291716002014","article-title":"Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses","volume":"46","author":"Lally","year":"2016","journal-title":"Psychological medicine"},{"key":"10.1016\/j.pnpbp.2020.109871_bb1005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pscychresns.2018.11.002","article-title":"Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia","volume":"282","author":"McNabb","year":"2018","journal-title":"Psychiatry Research: Neuroimaging"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109871_bb0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2215-0366(15)00540-4","article-title":"Brain-imaging studies of treatment-resistant schizophrenia: a systematic review","volume":"3","author":"Mouchlianitis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1\u20103","key":"10.1016\/j.pnpbp.2020.109871_bb0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2015.01.043","article-title":"Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia","volume":"164","author":"Nakajima","year":"2015","journal-title":"Schizophrenia research"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.109871_bb0160","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neubiorev.2010.11.004","article-title":"Dysconnectivity in schizophrenia: where are we now?","volume":"35","author":"Pettersson-Yeo","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109871_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awt310","article-title":"White matter integrity as a predictor of response to treatment in first episode psychosis","volume":"137","author":"Reis Marques","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11682-012-9152-9","article-title":"Anterior limb of the internal capsule in schizophrenia: a diffusion tensor tractography study","volume":"6","author":"Rosenberger","year":"2012","journal-title":"Brain Imaging Behav."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.109871_bb0175","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1469-8749.2012.04332.x","article-title":"New insights into the pathology of white matter tracts in cerebral palsy from diffusion magnetic resonance imaging: a systematic review","volume":"54","author":"Scheck","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109871_bb0180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/schbul\/sbx049","article-title":"Sex and diffusion tensor imaging of white matter in schizophrenia: a systematic review plus meta-analysis of the corpus callosum","volume":"44","author":"Shahab","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"Suppl 20","key":"10.1016\/j.pnpbp.2020.109871_bb0185","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.109871_bb0190","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.neuroimage.2006.02.024","article-title":"Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data","volume":"31","author":"Smith","year":"2006","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0195","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1006\/nimg.2002.1267","article-title":"Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water","volume":"17","author":"Song","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2020.109871_bb0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pscychresns.2017.09.014","article-title":"White matter and schizophrenia: a meta-analysis of voxel-based morphometry and diffusion tensor imaging studies","volume":"270","author":"Vitolo","year":"2017","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.109871_bb0205","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1176\/appi.ajp.160.3.572","article-title":"Inferior frontal white matter anisotropy and negative symptoms of schizophrenia: a diffusion tensor imaging study","volume":"160","author":"Wolkin","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.109871_bb0210","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1176\/appi.ajp.2018.17121402","article-title":"White matter abnormalities in never-treated patients with long-term schizophrenia","volume":"175","author":"Xiao","year":"2018","journal-title":"American Journal of Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619306888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584619306888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:50:28Z","timestamp":1759521028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584619306888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":40,"alternative-id":["S0278584619306888"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109871","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109871"}}